Compared to a selective GLP-1 receptor agonist, the synergistic action of GIP combined with GLP-1 shows more effective weight loss and reduction in food intake with increased energy expenditure in genetic mouse models with diet-induced obesity [61]. The gene discussed is GIP; the disease is obesity due to melanocortin 4 receptor deficiency.